| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8B | $11.9B | $10.6B | $12.5B | $12.2B | $2.4B | $2.4B | $3.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.2B | $0.1B | $-0.7B | $-0.1B | $0.4B | $-0.0B | $-0.3B | $0.0B |
| EPS (Basic) | $4.40 | $0.26 | $-3.65 | $-0.68 | $2.30 | $-0.02 | $-1.63 | $0.23 |
| EPS (Diluted) | $4.37 | $0.26 | $-3.65 | $-0.68 | $2.26 | $-0.02 | $-1.63 | $0.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.1B | $14.1B | $14.2B | $14.8B | $15.0B | $14.9B | $14.6B | $15.9B |
| Current Assets | $5.5B | $4.9B | $4.4B | $5.3B | $5.0B | $4.5B | $3.5B | $4.1B |
| Cash & Equivalents | $1.6B | $1.1B | $0.9B | $1.4B | $1.8B | $1.6B | $0.9B | $1.1B |
| Total Liabilities | $9.9B | $8.9B | $8.3B | $8.2B | $8.7B | $9.8B | $8.7B | $8.5B |
| Current Liabilities | $3.8B | $3.4B | $3.0B | $3.0B | $3.2B | $2.8B | $2.6B | $2.9B |
| Stockholders' Equity | — | $5.2B | $4.3B | $5.1B | $4.7B | $3.3B | $4.1B | $5.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $0.6B | $0.1B | $0.8B | $0.9B | $0.4B | $0.7B | $0.4B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.6B | $-0.5B | $0.6B | $-0.2B | $-0.5B | $-0.4B |
| Capital Expenditures | $0.6B | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.3B | $0.2B | $0.1B | $-0.8B | $-1.2B | $0.5B | $-0.4B | $-0.3B |